Chroma Medicine
- Catherine Stehman-Breen
Catherine Stehman-Breen is the CEO at Chroma Medicine. She became CEO in 2020 after serving as Chief Research and Development Officer at Obsidian Therapeutics.
Catherine has a BA from Colby College, a MA fro the University of Washington, and an MD from The University of Chicago Pritzker School of Medicine.
Links
Previous companies
Org chart
Sign up to view 12 direct reports
Get started